Lastly, since CTC-count in itself is an independent prognostic factor, this can bias reports about the diagnostic accuracy and the prognostic value of the presence of HER2-positive CTCs in HER2-negative primary breast cancer patients[8, 10]. The gene discussed is ERBB2; the disease is breast cancer.